The overview discusses 58 peptides in several clinical phases, indicating a strong pipeline of peptide therapies targeting PPIs. In this way, peptide-based mostly drug development may be sizeable for the future of qualified treatment method.4 The rising incorporation of peptides in anti-growing old products marks an important pattern in the s